Cancer Urology

Онкоурология

1726-97761996-1812

Publishing House ABV Press

1050

10.17650/1726-9776-2008-4-1-59-62

REVIEW

ОБЗОР

Incidental prostate cancer

Инцидентальный рак предстательной железы

Marisov

L. V.

Марисов

Л. В.

Russian Federation

Vinarov

A. Z.

Винаров

А. З.

Russian Federation

Урологическая клиника ММА им. И.М. Сеченова

30032008

59621302202013022020

https://oncourology.abvpress.ru/oncur/article/view/1050

1. Argyropoulos A., Doumas K., Farmakis A. et al. Characteristics of patients with stage T1b incidental prostate cancer. Scand J Urol Nephrol 2005;39(4):289—93.

Argyropoulos A., Doumas K., Farmakis A. et al. Characteristics of patients with stage T1b incidental prostate cancer. Scand J Urol Nephrol 2005;39(4):289—93.

2. Murphy G., Khour S., Partin A., Denis L. Prostate cancer 1999.

Murphy G., Khour S., Partin A., Denis L. Prostate cancer 1999.

3. Prostate cancer: A killer among us. Cancer 2006; http://www.health.am/ab/more/prostate_cancer_a_killer_among_us/

Prostate cancer: A killer among us. Cancer 2006; http://www.health.am/ab/more/prostate_cancer_a_killer_among_us/

4. Лопаткин Н.А., Даренков А.Ф., Горюнов В.Г. Урология. 1995.

Лопаткин Н.А., Даренков А.Ф., Горюнов В.Г. Урология. 1995.

5. Коган М.И., Лоран О.Б., Петров С.Б. Радикальная хирургия рака предстательной железы. 2006.

Коган М.И., Лоран О.Б., Петров С.Б. Радикальная хирургия рака предстательной железы. 2006.

6. Пушкарь Д.Ю. Простатспецифический антиген и биопсия предстательной железы. 2003.

Пушкарь Д.Ю. Простатспецифический антиген и биопсия предстательной железы. 2003.

7. Guichard G., Larre’ S., Gallina A. et al. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients. Eur Urol 2007;52(2):430—5.

Guichard G., Larre’ S., Gallina A. et al. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients. Eur Urol 2007;52(2):430—5.

8. Anim J.T., Ebrahim B.H., Sathar S.A. Benign disorders of prostate: A histopathological study. Ann Saudi Med 1998;18(1):22—7.

Anim J.T., Ebrahim B.H., Sathar S.A. Benign disorders of prostate: A histopathological study. Ann Saudi Med 1998;18(1):22—7.

9. Урология. Под ред. Ю.Г. Аляева. 2005.

Урология. Под ред. Ю.Г. Аляева. 2005.

10.

10. Antunes A.A., Freire Gde C., Aiello Filho D. et al. Analysis of the risk factors for incidental carcinoma of the prostate in patients with benign prostatic hyperplasia. Clinics 2006;61(6):545—50.

Antunes A.A., Freire Gde C., Aiello Filho D. et al. Analysis of the risk factors for incidental carcinoma of the prostate in patients with benign prostatic hyperplasia. Clinics 2006;61(6):545—50.

11.

11. van Andel G., Vleeming R., Kurth K., de Reijke T.M. Incidental carcinoma of the prostate. Semin Surg Oncol 1995;11(1):36—45.

van Andel G., Vleeming R., Kurth K., de Reijke T.M. Incidental carcinoma of the prostate. Semin Surg Oncol 1995;11(1):36—45.

12.

12. Tombal B., De Visccher L., Cosyns J.P. et al. Assessing the risk of unsuspected prostate cancer in patients with benign prostatic hypertrophy: a 13-year retrospective study of the incidence and natural history of T1a-T1b prostate cancers. BJU Int 1999;84(9):1015—20.

Tombal B., De Visccher L., Cosyns J.P. et al. Assessing the risk of unsuspected prostate cancer in patients with benign prostatic hypertrophy: a 13-year retrospective study of the incidence and natural history of T1a-T1b prostate cancers. BJU Int 1999;84(9):1015—20.

13.

13. Meguro N., Maeda O., Saiki S. et al. Clinical significance of prostate specific antigen (PSA) and PSA density in the detection of T1a and T1b prostate cancer. Hinyokika Kiyo 1998;44(9):639—43.

Meguro N., Maeda O., Saiki S. et al. Clinical significance of prostate specific antigen (PSA) and PSA density in the detection of T1a and T1b prostate cancer. Hinyokika Kiyo 1998;44(9):639—43.

14.

14. Vecchioli Scaldazza C. Incidental carcinoma of the prostate. Study of 683 patients operated upon for benign prostatic hypertrophy. Minerva Urol Nefrol 1992;44(2):109—12.

Vecchioli Scaldazza C. Incidental carcinoma of the prostate. Study of 683 patients operated upon for benign prostatic hypertrophy. Minerva Urol Nefrol 1992;44(2):109—12.

15.

15. Zigeuner R.E., Lipsky K., Riedler I. et al. Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patients. Urology 2003;62(3):451—5.

Zigeuner R.E., Lipsky K., Riedler I. et al. Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patients. Urology 2003;62(3):451—5.

16.

16. Kanno H., Umemoto S., Izumi K. et al. Prostate cancer development after transurethral resection of the prostate--histopathological studies of radical prostatectomy specimens. Nippon Hinyokika Gakkai Zasshi 2006;97(4):649—59.

Kanno H., Umemoto S., Izumi K. et al. Prostate cancer development after transurethral resection of the prostate--histopathological studies of radical prostatectomy specimens. Nippon Hinyokika Gakkai Zasshi 2006;97(4):649—59.

17.

17. Picurelli Oltra L., Sendra Torres A., Fernandez Rodriguez A. et al. Incidental prostatic adenocarcinoma in the ere of the PSA. Actas Urol Esp 1997;21(4):354—6.

Picurelli Oltra L., Sendra Torres A., Fernandez Rodriguez A. et al. Incidental prostatic adenocarcinoma in the ere of the PSA. Actas Urol Esp 1997;21(4):354—6.

18.

18. Herranz Amo F., Diez Cordero J.M., Verdu Tartajo F. et al. Incidental prostatic cancer Actas Urol Esp 1999;23(10): 848—52.

Herranz Amo F., Diez Cordero J.M., Verdu Tartajo F. et al. Incidental prostatic cancer Actas Urol Esp 1999;23(10): 848—52.

19.

19. Mai K.T., Isotalo P.A., Green J. et al. Incidental prostatic adenocarcinomas and putative premalignant lesions in TURP specimens collected before and after the introduction of prostrate-specific antigen screening Arch Pathol Lab Med 2000;124(10):1454—6.

Mai K.T., Isotalo P.A., Green J. et al. Incidental prostatic adenocarcinomas and putative premalignant lesions in TURP specimens collected before and after the introduction of prostrate-specific antigen screening Arch Pathol Lab Med 2000;124(10):1454—6.

20.

20. Monda J.M., Barry M.J., Oesterling J.E. Prostate specific antigen cannot distinguish stage T1a (A1) prostate cancer from benign prostatic hyperplasia. J Urol 1994;151(5):1291—5.

Monda J.M., Barry M.J., Oesterling J.E. Prostate specific antigen cannot distinguish stage T1a (A1) prostate cancer from benign prostatic hyperplasia. J Urol 1994;151(5):1291—5.

21.

21. Paul R., Knebel C., van Randenborgh H. et al. Incidental carcinoma of the prostate: can we and should we recommend radical prostatectomy. Urologe A 2005;44(9):1052, 1054—8.

Paul R., Knebel C., van Randenborgh H. et al. Incidental carcinoma of the prostate: can we and should we recommend radical prostatectomy. Urologe A 2005;44(9):1052, 1054—8.

22.

22. Leisinger H.J. Cancer of the prostate stage T1. Inci dental carcinoma. Review of the literature and an appraisal of the classification. Ann Urol (Paris) 1994;28(4): 229—34.

Leisinger H.J. Cancer of the prostate stage T1. Inci dental carcinoma. Review of the literature and an appraisal of the classification. Ann Urol (Paris) 1994;28(4): 229—34.

23.

23. Capitanio U., Scattoni V., Freschi M. et al. Factors predicting pathological stage in patients submitted radical retropubic prostatectomy due to incidental (T1a-T1b) prostate cancer. Eur Urol 2007;(Suppl).

Capitanio U., Scattoni V., Freschi M. et al. Factors predicting pathological stage in patients submitted radical retropubic prostatectomy due to incidental (T1a-T1b) prostate cancer. Eur Urol 2007;(Suppl).

24.

24. Robinson D., Aus G., Bak J. et al. Long-term follow-up of conservatively managed incidental carcinoma of the prostate: a multivariate analysis of prognostic factors. Scand J Urol Nephrol 2007;41(2):103—9.

Robinson D., Aus G., Bak J. et al. Long-term follow-up of conservatively managed incidental carcinoma of the prostate: a multivariate analysis of prognostic factors. Scand J Urol Nephrol 2007;41(2):103—9.

25.

25. Allue Lopez M., Allepuz Losa C., Borque Fernando A. et al. Incidental prostatic cancer: T1a-T1b. Our experience after observation/radical surgery and literature review Actas Urol Esp 2006;30(8):749-53; discussion 753.

Allue Lopez M., Allepuz Losa C., Borque Fernando A. et al. Incidental prostatic cancer: T1a-T1b. Our experience after observation/radical surgery and literature review Actas Urol Esp 2006;30(8):749-53; discussion 753.

26.

26. Bostwick D.G. The pathology of incidental carcinoma. Cancer Surv 1995;23: 7—18.

Bostwick D.G. The pathology of incidental carcinoma. Cancer Surv 1995;23: 7—18.

27.

27. Masue N., Deguchi T., Nakano M. et al. Retrospective study of 101 cases with incidental prostate cancer stages T1a and T1b Six-year follow-up of untreated T1 carcinoma of prostate. Int J Urol 2005;12(12):1045—9.

Masue N., Deguchi T., Nakano M. et al. Retrospective study of 101 cases with incidental prostate cancer stages T1a and T1b Six-year follow-up of untreated T1 carcinoma of prostate. Int J Urol 2005;12(12):1045—9.

28.

28. Heidenreich A., Aus G., Abbou C.C. et al. Guidelines on prostate cancer. EAU Guidelines; 2007.

Heidenreich A., Aus G., Abbou C.C. et al. Guidelines on prostate cancer. EAU Guidelines; 2007.